Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy.
PLoS One
; 12(8): e0184112, 2017.
Article
en En
| MEDLINE
| ID: mdl-28850595
PURPOSE: To compare the efficacy of the subthreshold micropulse laser (SML) to conventional laser (CL) in treating focal leakages of the retinal pigment epithelium (RPE) in the eyes with central serous chorioretinopathy (CSC). METHODS: Twenty-nine eyes of 28 patients with CSC and typical focal leakage were treated with CL or SML. Both treatments were made with a 577 nm yellow laser (CL: NIDEK MC-500, SML: IRIDEX IQ577). The percentage of eyes with a complete resolution, the distance of the laser burns from the fovea, and injury of the RPE after treatment were studied. RESULTS: A complete resolution was seen in 10 of 15 eyes (66.7%) after CL and 9 of 14 eyes (64.3%) after SML (P = 0.89). The average distance from the foveal center to the leakage point was 1282±596 µm for eyes treated with CL and 1271±993 µm for eyes treated with SML (P = 0.4). Only three eyes treated with SML had treatment sites within 500 µm of the fovea. RPE damage determined by fundus autofluorescence was found in all eyes treated with CL and only one eye treated with SML (P<.01). CONCLUSIONS: SML achieved equivalent therapeutic effects as CL but without RPE damage in eyes with CSC.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Terapia por Láser
/
Coriorretinopatía Serosa Central
Tipo de estudio:
Observational_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
PLoS One
Asunto de la revista:
CIENCIA
/
MEDICINA
Año:
2017
Tipo del documento:
Article
País de afiliación:
Japón
Pais de publicación:
Estados Unidos